SANTA ANA, Calif. - NKGen Biotech, Inc. (NASDAQ: NKGN), a clinical-stage biotechnology company with a current market capitalization of $17 million, has received Fast Track designation from the U.S.

Company to assess alternate payloads; no changes planned to novel capsid component - - Resulting shift of timeline and costs ...

Revenues of €9.2 million for the full year of 2024Cash and cash equivalents at €96.6 million as of December 31, 2024 First tranche of up to €348 ...

Vivos Inc. (OTCQB: RDGL) is pleased to report that the first five patients demonstrated the safety of RadioGel Precision ...

A police general who was linked to the P6.7-billion drug haul in Manila in 2022 has flown out of the country as authorities hunt down active and former cops accused in the controversial “bogus” and ...

A police general who was linked to the P6.7-billion drug haul in Manila in 2022 has flown out of the country as authorities hunt down active and former cops accused in the controversial “bogus ...

The “initial rescissions” order, signed in front of cheering crowds at the Capital One Arena, revokes dozens of Biden administration policies that the new White House called inflammatory ...

The memo, sent by acting Homeland Security Secretary Benjamine Huffman, says DHS is granting immigration-enforcement authority to several agencies at the Justice Department, including the Drug ...

GLP-1RA drugs like Ozempic offer significant health benefits, including weight loss, improved brain health, and reduced addiction risks, but also pose risks like pancreatitis and kidney issues.

Ziyad Al-Aly receives funding from U.S. Department of Veterans Affairs. Several years ago, a little-known drug named Ozempic – previously used only to treat diabetes – emerged as a promising ...

President Trump pardoned Ross Ulbricht, the founder of notorious 2010s drug trafficking website Silk ... the Federal Courthouse on May 29, 2015 in New York. (DON EMMERT/AFP via Getty Images ...

The new prices are expected to take effect in 2027. Between November 2023 and October 2024, these selected drugs accounted for about $41 billion in total covered prescription drug costs under Medicare ...